Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2024
Reporting Period: Fiscal fourth quarter and full year ended June 30, 2024.
Context: The Company issued a press release announcing preliminary unaudited revenue results for the specified periods. The Company is an emerging growth company.
Key Financial Metrics
The filing text references the announcement of preliminary unaudited revenue results but does not contain the specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the accompanying press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
The filing does not provide specific data to compare current results against prior comparable periods. It only confirms the issuance of preliminary results for the fiscal year ended June 30, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing serves as a notification of the press release regarding preliminary revenue results.
Legal Disclaimer: The information in this report and its exhibits is not incorporated by reference into other filings and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Guidance/Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed in the text of this 8-K form.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated September 9, 2024) for the specific preliminary revenue figures for Q4 and full year 2024.
- Verify the unaudited nature of the reported results and compare them against previously issued guidance or analyst estimates.
- Confirm the Company's status as an emerging growth company and any implications for financial reporting standards.
- Check subsequent filings for the audited financial statements to reconcile with these preliminary figures.